GPx Raises $500 Million To Support Emerging VCs And Lead Later-Stage Investments

GPx, the new venture firm co-founded by Brian Singerman (former Founders Fund GP) and Lee Linden (co-founder and managing partner of Quiet Capital), is raising over $500 million for a fresh twist on the VC model. With backing likely from Founders Fund co-founder Peter Thiel, GPx combines a partial fund-of-funds approach — investing about 20% into emerging VCs at the pre-seed and seed stages — while reserving the rest to partner with these managers to lead later-stage investments in their breakout companies. Singerman and Linden’s strategy aims to help nimble new VCs scale their best bets, overcoming the pro-rata funding squeeze many early-stage investors face. AMOUNT: $500,000,000 #VentureCapital #GPx #LeeLinden #BrianSingerman #PeterThiel #TradedVC

More Deals

View All

Mercor In Talks To Raise $20 Billion Following Deeptune Acquisition And Revenue GrowthMercor, an AI training startup, is reportedly in early discussions to raise a new funding round at a $20 billion valuation. The potential valuation would double the company’s $10 billion valuation from October 2025, when it raised a $350 million Series C round. Founder and CEO Brendan Foody recently stated that Mercor’s annualized revenue run rate has surpassed $2 billion, representing 100% growth in just four months. The company also announced the acquisition of Deeptune, an AI agent training firm, with the entire Deeptune team joining Mercor. The strong revenue growth, acquisition activity, and prospective funding round suggest Mercor is continuing to expand despite challenges earlier this year, including a data breach and legal disputes involving contract workers. FOUNDER: Brendan Foody AMOUNT: $20,000,000,000 HQ: San Francisco, California #VentureCapital #Mercor #BrendanFoody #TradedVC

Klinic Secures $24 Million In Seed And Series A Funding From Proofpoint Capital And I2BF Global VenturesKlinic, an AI-enabled specialty care access platform, has raised $24 million in combined seed and Series A funding to expand its provider network, enhance its AI-powered platform, and grow its life sciences partnerships. The round was co-led by Proofpoint Capital and I2BF Global Ventures, with representatives from both firms joining Klinic’s board. Founded and led by CEO Avish Bhama, Klinic helps patients navigate the often complex specialty care journey by using artificial intelligence and workflow automation to streamline provider matching, insurance verification, prior authorizations, patient communications, and pharmacy coordination. The company has already supported more than 150,000 patients and aims to make specialty care access faster, more connected, and more affordable. FOUNDER: Avish Bhama INVESTORS: Proofpoint Capital & I2BF Global Ventures ROUND: Seed & Series A AMOUNT: $24,000,000 HQ: Dallas, Texas #VentureCapital #Klinic #AvishBhama #TradedVC